According to DelveInsight's analysis, the chondrosarcoma market size was found to be ~USD 15 million in the 7MM in 2025, and it is projected to grow at a CAGR of 16% during 2026–2036. Among the 7MM, ...
Portable, cartridge-based multiplex systems, digital integration, and expansion into oncology and remote care drive point-of-care molecular diagnostics adoption.Dublin, Oct. (GLOBE NEWSWIRE) -- "Point ...
Outsourced sequencing, reimbursed clinical pathways, oncology demand and hospital adoption offer strong ROI opportunities in Thailand’s precision medicine ecosystem.Dublin, Oct. (GLOBE NEWSWIRE) -- ...